Financial Gravity Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$961 Buy
+12
New +$989 ﹤0.01% 759
2025
Q1
$870 Buy
+12
New +$859 ﹤0.01% 889
2024
Q2
Sell
-1
Closed -$136 1754
2024
Q1
$136 Sell
1
-18
-95% -$1.51K ﹤0.01% 1690
2023
Q4
$1.3K Buy
19
+2
+12% +$139 ﹤0.01% 1026
2023
Q3
$1.11K Sell
17
-77
-82% -$6.19K ﹤0.01% 753
2023
Q2
$224 Buy
94
+11
+13% +$956 ﹤0.01% 1163
2023
Q1
$202 Buy
+83
New +$6.52K 0.01% 611
2022
Q4
Sell
-249
Closed -$202 1445
2022
Q3
$202 Sell
249
-36
-13% -$3.46K 0.01% 548
2022
Q2
$233 Sell
285
-69
-19% -$7.14K 0.01% 508
2022
Q1
$288 Sell
354
-36
-9% -$4.04K 0.01% 515
2021
Q4
$317 Buy
390
+388
+19,400% +$45.3K 0.01% 564
2021
Q3
$113K Buy
+2
New +$228 0.05% 318
2021
Q2
Sell
-2
Closed -$205 985
2021
Q1
$205 Sell
2
-2
-50% -$169 ﹤0.01% 453
2020
Q4
$0 Buy
+4
New +$332 ﹤0.01% 532
2020
Q2
Sell
-15
Closed -$859 281
2020
Q1
$859 Sell
15
-300
-95% -$21.6K ﹤0.01% 492
2019
Q4
$233K Hold
315
0.16% 92
2019
Q3
$23K Buy
315
+240
+320% +$16.9K 0.02% 431
2019
Q2
$5K Sell
75
-9
-11% -$544 ﹤0.01% 684
2019
Q1
$5K Buy
+84
New +$4.79K ﹤0.01% 677
2018
Q3
$52K Buy
1,131
+924
+446% +$45.2K 0.05% 308
2018
Q2
$9K Sell
207
-57
-22% -$2.66K 0.01% 586
2018
Q1
$12K Buy
+264
New +$11.5K 0.01% 562

Other funds holding EW

Financial Gravity Asset Management's EW Position: Q1 2026 in Review

Financial Gravity Asset Management opened a new position in Edwards Lifesciences (EW) in Q1 2026: 12 shares worth $961. The stake represents ﹤0.01% of the portfolio and ranks #759 among its holdings. This is a return to the name: Financial Gravity Asset Management previously reported a position in EW as recently as Q1 2025.

Financial Gravity Asset Management first reported a position in EW in Q1 2018 and has held it in 22 quarters since. The position peaked at $233K in Q4 2019. 1,288 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Financial Gravity Asset Management held 12 shares of Edwards Lifesciences worth $961 as of Q1 2026.
  • Edwards Lifesciences was a new Financial Gravity Asset Management position in Q1 2026.
  • Edwards Lifesciences made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q1 2026, its #759 holding.
  • Financial Gravity Asset Management first reported a position in Edwards Lifesciences in Q1 2018 and has held it in 22 quarters since.
  • Financial Gravity Asset Management's Edwards Lifesciences position peaked at $233K in Q4 2019.
  • 1,288 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Financial Gravity Asset Management's 13F filing for Q1 2026, filed 8 May 2026.